Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index; 3 of the 11 sources its claims cite were checked for support.
Abstract
The quantitative contributions of pancreatic responsiveness and insulin sensitivity to glucose tolerance were measured using the "minimal modeling technique" in 18 lean and obese subjects (88-206% ideal body wt). The individual contributions of insulin secretion and action were measured by interpreting the dynamics of plasma glucose and insulin during the intravenous glucose tolerance test in terms of two mathematical models. One, the insulin kinetics model, yields parameters of first-phase (phi 1) and second-phase (phi 2) responsivity of the beta-cells to glucose. The other glucose kinetics model yields the insulin sensitivity parameters, SI. Lean and obese subjects were subdivided into good (KG greater than 1.5) and lower (KG less than 1.5) glucose tolerance groups. The etiology of lower glucose tolerance was entirely different in lean and obese subjects. Lean, lower tolerance was related to pancreatic insufficiency (phi 2 77% lower than in good tolerance controls [P less than 0.03]), but insulin sensitivity was normal (P greater than 0.5). In contrast, obese lower tolerance was entirely due to insulin resistance (SI diminished 60% [P less than 0.01]); pancreatic responsiveness was not different from lean, good tolerance controls (phi 1: P greater than 0.06; phi 2: P greater than 0.40). Subjects (regardless of weight) could be segregated into good and lower tolerance by the product of second-phase beta-cell responsivity and insulin sensitivity (phi 2 . SI). Thus, these two factors were primarily responsible for overall determination of glucose tolerance. The effect of phi 1 was to modulate the KG value within those groups whose overall tolerance was determined by phi 2 . SI. This phi 1 modulating influence was more pronounced among insulin sensitive (phi 1 vs. KG, r = 0.79) than insulin resistant (obese, low tolerance; phi 1 vs. KG, r = 0.91) subjects. This study demonstrates the feasibility of the minimal model technique to determine the etiology of impaired glucose tolerance.
Overview
CoChat Summary
TL;DR
The paper applies the “minimal modeling” technique to intravenous glucose tolerance tests in 18 lean and obese subjects to quantify insulin sensitivity and β-cell glucose responsiveness. It finds that low glucose tolerance in lean subjects is due mainly to pancreatic insufficiency, whereas in obese subjects it is due mainly to insulin resistance.
Key findings
- Lean subjects with lower glucose tolerance had a 77% lower second-phase β-cell responsivity (φ2) than lean good-tolerance controls (P < 0.03), while insulin sensitivity was normal (P > 0.5).
- Obese subjects with lower glucose tolerance had insulin sensitivity diminished by 60% versus lean good-tolerance controls (P < 0.01), with pancreatic responsiveness not significantly different (φ1: P > 0.06; φ2: P > 0.40).
- The product φ2·S segregated tolerance: good-tolerance subjects averaged 160 ± 26 versus 40 ± 7 for low-tolerance subjects (P < 0.001); a φ2·S threshold of 75 separated 9 of 10 low-tolerance and 7 of 8 good-tolerance subjects.
- First-phase responsivity (φ1) modulated KG within groups: φ1 vs KG correlated r = 0.79 in insulin-sensitive subjects and r = 0.91 in insulin-resistant obese low-tolerance subjects; glucose effectiveness (P1) was lower in low-tolerance subjects (1.4 ± 0.2 vs. 3.6 ± 0.3 %/min, P < 0.01).
Methods
- IVGTT was performed in 18 subjects (8 male, 10 female; 88–206% ideal body weight) after an overnight fast, with 300 mg/kg glucose injected over 60 s and frequent plasma glucose and insulin sampling.
- Two minimal mathematical models were used: a glucose kinetics model to estimate insulin sensitivity (S) and an insulin kinetics model to estimate first-phase (φ1) and second-phase (φ2) β-cell responsivity to glucose.
- Parameters were estimated by nonlinear least squares with covariance-matrix accuracy assessment; subjects were divided into good tolerance (KG > 1.5) and lower tolerance (KG < 1.5), and comparisons used Student’s t test and regression.
Limitations
- The paper states that complete validation of the model and optimal input patterns is required before the approach can be proposed as a clinical tool, and that more study of the range of glucose doses over which the model applies would be worthwhile.
- The authors note that the present studies were limited to testing whether the model and its parameters apply and can be obtained from other doses and stimulus patterns.
- Evident from the text: the sample is small (n = 18), the tolerance cutoff at KG = 1.5 was arbitrary because no KG values fell between 1.4 and 1.8, and φ1 varied widely within groups, limiting clear segregation by φ1·S.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




![FiGURE 4 Ability of the minimal models to describe glucose and insulin kinetics during the IVGTT (examples). Insulin and glucose data are represented by open (O) and filled () circles. Prediction of the insulin kinetics model are the solid curves; upper panels. Glucose kinetics model predicts the time-course of plasma glucose (solid curves, lower panels) as well as the timecourse of "insulin action" (dashed line upper panels; remote insulin [X] in the model of Fig. la).](https://figures.cochat.ai/paper-figures/f6e06f75ebdc4bef964605372991c28c/physiologic-evaluation-of-factors-controlling-glucose-tolerance-in-man-figure-4.png)



Verification
Claims the paper makes
2 Valid · 0 Not valid · 4 Not checked · 44 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“During the past decade, several laboratories have approached this problem by breaking the feedback relationship, either by pharmacological suppression of pancreatic insulin secretion (10) or by external feedback control (glucose clamp) to circumvent the effect of plasma insulin to change plasma glucose (11).”
What the sources say
- Supportedcites [10] 10. Shen, S-W., G. M. Reaven, and J. W. Farquhar. 1970. Comparison of impedance to insulin-mediated glucose uptake in normal and diabetic subjects.J. Clin. Invest. 49: 2151-2160. source
The Introduction (p. 1, 'Dr. Shen is a Postdoctoral Research Fellow' section) states the approach the citing sentence attributes to this reference: subjects received a constant intravenous infusion of exogenous crystalline insulin while 'endogenous insulin secretion was inhibited by the simultaneous administration of low doses of epinephrine and propranolol,' so that the steady-state plasma glucose during a constant glucose infusion measures impedance to insulin-mediated glucose uptake, and such measurements 'should eliminate some of the variables of an intact feedback loop.' The Discussion ('§ Values obtained from') confirms the pharmacological blockade worked (immunoreactive insulin fell to <50% of fasting and remained low despite plasma glucose of 316 and 398 mg/100 ml), and that its primary goal was to consider only a constant level of exogenous insulin. Our copy does not describe external feedback control (glucose clamp), but that half of the sentence is carried by the separate citation (11), not by this source; likewise 'during the past decade, several laboratories' is the citing authors' framing. Note the propranolol-epinephrine inhibition method is credited to Porte (ref 36), but Shen et al. report and rely on it as their own experimental approach, so the identification citation stands. (LLM, conf=0.88)
- Supportedcites [11] 11. Insel, P. A., J. E. Liljenquist, J. D. Tobin, R. S. Sherwin, P. Watkins, R. Andres, and M. Berman. 1975. Insulin control of glucose metabolism in man. J. Clin. Invest. 55: 1057-1066. source
The citation is attached to the glucose-clamp branch of the sentence (the pharmacological-suppression branch carries a different reference), and our copy is exactly that kind of work: the Introduction (p. 1057) states that 'the maintenance of blood sugar in man is a complex process involving feedback control of insulin on glucose and of glucose on insulin' and that 'by use of the glucose clamp technique (1, 2), the blood glucose concentration is maintained by a feedback-controlled glucose infusion.' The Abstract (p. 1057) confirms the purpose — insulin-induced changes in blood glucose activate counterregulatory mechanisms, 'to eliminate such mechanisms, we have employed the glucose clamp technique which allows maintenance of fasting blood glucose concentration,' and the Discussion (p. 1063) presents the clamp (with kinetic modeling) as an approach to estimating tissue sensitivity to insulin, contrasting it with the insulin tolerance test and 'glucose impedance.' The 'several laboratories' framing is the citing authors' own summary, not a point attributed to this source. (LLM, conf=0.85)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Thus, our results are consistent with the diminished S of obese subjects elucidated by both qualitative (26) and quantitative techniques (25).”
What the sources say
- Not checked — no full text of the sourcecites [26] 26. Kolterman, O., G. M. Reaven, and J. M. Olefsky. 1979. Relationship between in vivo insulin resistance and decreased insulin receptors in obese men. J. Clin. Endocrinol. Metab. 48: 487-494. source
- Supportedcites [25] 25. DeFronzo, R., V. Soman, R. Sherwin, R. Hendler, and P. Felig. 1979. Insulin binding to monocytes and insulin action in human obesity, starvation and refeeding. J. Clin. Invest. 63: 204–213. source
The citation is attached to “quantitative techniques.” The Discussion reports that insulin sensitivity was quantified with the euglycemic insulin clamp and was 52% lower in postabsorptive obese subjects. This supports the attributed finding of diminished insulin sensitivity (S); the qualitative-techniques citation is separate. (LLM, conf=0.93)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the obese glucose space exceeded the space of lean individuals by only 16% (Table II).”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“an increase of φ1 from 1 to 10 was associated with an increase in KG of only 0.3 min−¹.”
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on 2 assumptions not shown here.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Because the diminished glucose effectiveness of obese subjects is independent of acute changes in insulin”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
27 more claims
Create a free account to see all 50 claims and every source verdict.
- Probably not a substantial claim. 8
- It may state two separate claims as one. 14
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As postulated previously [93], we found that the relationship between insulin sensitivity and insulin secretion is non-linear and best described by a hyperbolic function.”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [93]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These studies have demonstrated that to maintain glucose homeostasis, a feedback loop exists in which decreased insulin sensitivity is tightly associated with increased insulin secretion from the beta cell, with this hyperbolic relationship between beta cell responsivity and insulin sensitivity termed the disposition index67,68.”
From 100 years of insulin: celebrating the past, present and future of diabetes therapy (2021) · cites this paper as [68]
Experimental — accuracy not yet measuredIn the citing paper
“the product of insulin sensitivity and the acute insulin response to intravenous glucose, called the disposition index [93], declined in the group as a whole and was associated with a mild deterioration of intravenous glucose tolerance.”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [93]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| 6 | 1.06 | 8.9 | 5.1 | 1.4 | 4.5 |”
Reported 4.5 · recomputed 45.39
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ RESULTS · p. 7
“In the glucose kinetics model (Fig. 1b) the coefficient P1 is the insulin-independent fractional turnover constant for glucose disposition”
§ B MINIMAL MODEL OF INSULIN KINETICS · p. 3
“(B) Model of insulin kinetics used to calculate pancreatic responsivity parameters φ1 and φ2 (12).”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ METHODS · p. 2
“glucose (300 mg/kg) was injected smoothly over 60 s, starting at time (t) = 0.”
§ RESULTS · p. 6
“Glucose (330 mg/kg) was injected over 1 min starting at t = 0.”
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
Cited work 10.1172/jci109108 · retraction date not known · this paper published 1981-12-01
Citations
Cites
1 retracted
Insulin Binding to Monocytes and Insulin Action in Human Obesity, Starvation, and Refeeding
Defronzo, R. A., Soman, V., Sherwin, R. S., Hendler, R., & Felig, P. (1978) · Journal of Clinical Investigation · doi:10.1172/jci109108 · Cited by 252
RetractedQuantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 4×
“We have referred to the sum of these factors as "glucose effectiveness" (13).”
InfluentialSelf-citationExcessive Insulin Response to Glucose in Obese Subjects as Measured by Immunochemical Assay
Karam, J. H., Grodsky, G. M., Forsham, P. H., & McWilliams, N. B. (1963) · Diabetes · doi:10.2337/diab.12.3.197 · Cited by 591
Rabinowitz, D., & Zierler, K. L. (1962) · Journal of Clinical Investigation · doi:10.1172/jci104676 · Cited by 521
Shen, S.-W., Reaven, G. M., & Farquhar, J. W. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106433 · Cited by 494
A model of the kinetics of insulin in man
Sherwin, R. S., Kramer, K. J., Tobin, J. D., Insel, P. A., Liljenquist, J. E., Berman, M., & Andres, R. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107697 · Cited by 460
A threshold distribution hypothesis for packet storage of insulin and its mathematical modeling
Grodsky, G. M. (1972) · Journal of Clinical Investigation · doi:10.1172/jci107011 · Cited by 395
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Statistical Analysis: A Computer Oriented Approach.
Pektau, A. J., Afifi, A. A., & Azen, S. P. (1980) · Journal of the American Statistical Association · doi:10.2307/2287217 · Cited by 324
Toffolo, G., Bergman, R. N., Finegood, D. T., Bowden, C. R., & Cobelli, C. (1980) · Diabetes · doi:10.2337/diab.29.12.979 · Cited by 292
Self-citation
Research works printed but not linked: 2
- [18]18. Goodwin, C., and R. L. Payne. 1977. Dynamic System Identification. Academic Press, Inc., New York.
- [14]14. Bergman, R. N., C. R. Bowden, and C. Cobelli. 1981. The minimal model approach to quantification of factors controlling glucose disposal in man. In Carbohydrate Metabolism: Quantitative Physiology and Mathematical Modeling. C. Cobelli, and R. Bergman, editors. John Wiley & Sons, Inc., London. 269–296.
Cited by
Items 1,501–1,600 of 1,647
Yang, R., TARN, T. J., & Zhang, M. (2008) · Proceedings - IEEE International Conference on Robotics and Automation/Proceedings · doi:10.1109/robot.2008.4543244
Is the β‐cell the key for remission of diabetes after bariatric surgery?
Magkos, F., & Klein, S. (2015) · The Journal of Physiology · doi:10.1113/jp270782
HOMA-IR and Its Association with Metabolic Risk Factors among Korean Adolescents
Seo, E., Lee, S. G., Kim, S. H., & Park, M. J. (2011) · Korean Journal of Pediatric Gastroenterology and Nutrition · doi:10.5223/kjpgn.2011.14.4.376
Ibbini, M. S. (2009) · Journal of Medical Engineering & Technology · doi:10.1080/03091900903177256
Predictive Models for Type 1 Diabetes. A Case Study
Herget, J. (2009) · Lund University Publications Student Papers (Lund University)
Insulin Control System for Diabetic Patients by Using Adaptive Controller
Daneshvar, M., & Aminifar, S. (2011)
Omar, B. A., Reimer, M. K., Enerbäck, S., & Åhrén, B. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00296.2015
NOVEL CANINE MODELS OF OBESE PRE-DIABETES AND OF
Ionut, V., Liu, H., Mooradian, V., et al. (2009)
Self-citationUtzschneider, K. M., Prigeon, R. L., Faulenbach, M. V., Tong, J., Carr, D. B., Boyko, E. J., McNeely, M. J., Fujimoto, W. Y., & Kahn, S. E. (2008)
Evidence of Interaction Between PPARG2 and HNF4A Contributing to Variation in Insulin Sensitivity in
Black, M. H., Fingerlin, T. E., Allayee, H., Zhang, W., Xiang, A. H., Trigo, E., Hartiala, J., Lehtinen, A. B., Haffner, S. M., Bergman, R. N., et al. (2008)
Self-citationLosada, D. F. S., Betancourt, F. I. R., Javela, J. F. P., et al. (2010) · Revista de Investigaciones UNAD · doi:10.22490/25391887.682
A COMPARISON OF SEVERAL MATHEMATICAL GLUCOSE-INSULIN DYNAMICS MODELS
Cho, Y., & Sheen, D. (2011) · 한국산업응용수학회 학술대회 논문집
Assessment and Treatment of Impaired Insulin- Secretion and Action in Type 2 Diabetes
Dorkhan, M. (2008) · Lund University Publications (Lund University) · Cited by 1
Insulin sensitivity tools for critical care.
Blakemore, A. (2009) · UC Research Repository (University of Canterbury) · doi:10.26021/2005
Robust Modelling of the Glucose-Insulin System for Tight Glycemic Control of Critical Care Patients
Lin, J. (2007) · UC Research Repository (University of Canterbury) · doi:10.26021/1585 · Cited by 4
Olveira, G., Tapia, M. J., Ocón, J., Cabrejas-Gómez, C., Ballesteros-Pomar, M. D., Vidal‐Casariego, A., Irigoyen, C. A., Olivares, J., Conde-García, M. C., García‐Manzanares, Á., et al. (2015) · Cited by 1
Widenmaier, S. B. (2010) · cIRcle (University of British Columbia) · doi:10.14288/1.0071070
The Impact of Insulin and Insulin Therapy on Physiology in Critical Illness
Suhaimi, F. M. (2012) · UC Research Repository (University of Canterbury) · doi:10.26021/1869
Bohlooly-Yeganeh, M. (2001) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Role of the Artificial Pancreas in the Understanding of the Mode of Action of Insulin
Lambotte, L. (1983) · Lecture notes in medical informatics · doi:10.1007/978-3-642-48334-9_15
Métabolisme des glucides et méthodes d’exploration chez l’homme
Andréelli, F. (2012) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(12)40468-1
Passive insulin infusion using AVK method
Tatari, F., & Mazouchi, M. (2011) · International Conference on Control, Instrumentation, and Automation · doi:10.1109/icciautom.2011.6355889
Impact of polycystic ovary syndrome on the course of the menopausal period
Stachowiak, G., Zając, A. E., & Pertyński, T. (2013) · Menopause Review/Przegląd Menopauzalny · doi:10.5114/pm.2013.35073
Modelling Type 1 Diabetes Mellitus Blood Glucose Dynamics as a Monotone System
Sootla, A., & Cescon, M. (2016) · ORBi (University of Liège)
Polycystic Ovary Syndrome, Insulin Resistance and Cardiovascular Disease
Corcoran, M. H., & Ehrmann, D. A. (2002) · CRC Press eBooks · doi:10.1201/b14062-10
Åhrén, B., & Pacini, G. (2016)
Diagnose, Klassifikation und Klinik des Diabetes mellitus sowie der Hypoglykämien
Michaelis, D., & Ziegler, M. (1989) · Springer eBooks · doi:10.1007/978-3-7091-7562-0_7
Blutzuckerregelung des Menschen
Lunze, K., & Brendel, M. D. (2016) · Springer eBooks · doi:10.1007/978-3-642-41239-4_11
Mathematical Modeling of the PI3K-AKT-TOR Pathway
PhD, G. W. (2013) · CRC Press eBooks · doi:10.1201/b16259-18
EFFECT OF PHYSICAL EXERCISE ON GLUCOSE EFFECTIVENESS
Tokuyama, K. (1997) · 体力科學 · doi:10.7600/jspfsm1949.46.343
Novel Biomarkers and Genetic Variants for Type 2 Diabetes in Latinos
Kim, J. (2015) · Cited by 1
Estimation of processes with a high-mix of disturbance
Harirchi, F. (2014) · Digital Collections of Colorado (Colorado State University) · doi:10.13140/rg.2.1.1815.4404
Review Article The biochemical assessment of insulin resistance
Borai, A., Livingstone, C., & Ferns, G. A. (2007)
Mechanisms of fatty acid induced decrease in β-cell function.
Oprescu, A. I. (2009) · TSpace (University of Toronto)
A reduced sampling protocol for the identification of insulin sensitivity
Nguyen, H. T., Coates, P. A., Luzio, S. D., & Owens, D. R. (2002) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/iembs.1996.646411
PK/PD modelling of subcutaneous glucose dynamics
Hansen, A. H. (2013)
The Association of Vitamin D with Metabolic Disorders Underlying Type 2 Diabetes
Kayaniyil, S. (2012) · TSpace (University of Toronto)
Wearn, J. G. (2010) · VTechWorks (Virginia Tech)
Continuous glucose monitoring for optimising glycaemic performance in individuals without diabetes.
Thomas, F. (2017) · ORBi (University of Liège) · doi:10.26021/3044
Assessment of putative risk factors in the development of Diabetic Retinopathy in Wales
Chowdhury, S. R. (2016) · ORCA Online Research @Cardiff (Cardiff University)
Mori, H., & Kitamura, S. (1988) · IFAC Proceedings Volumes · doi:10.1016/s1474-6670(17)54898-3
Role of Insulin Error on Minimal Model Parameter Estimates in Various IVGTT Protocols
Ruggeri, A., & Cobelli, C. (1994) · IFAC Proceedings Volumes · doi:10.1016/s1474-6670(17)46244-6
Self-citationMeasurement in Lymph: Metabolic Insights from Sampling the Remote Compartment
Bergman, R. N., Steil, G. M., Ader, M., Poulin, R. A., & Bradley, D. C. (1994) · IFAC Proceedings Volumes · doi:10.1016/s1474-6670(17)46252-5
Self-citationVitamin D and Type 2 Diabetes Mellitus in an Aboriginal Community
Mansuri, S. (2014) · TSpace (University of Toronto) · Cited by 3
Study of Two Time Delays in IVGTT Glucose–Insulin Dynamical System
Rathee, S., & Nilam (2017) · International Journal of Applied and Computational Mathematics · doi:10.1007/s40819-017-0421-6
Part A: Type 1 Diabetes Mellitus
Zavitsanou, S., Mantalaris, A., Georgiadis, M. C., & Pistikopoulos, E. N. (2017) · Wiley eBooks · doi:10.1002/9781118965580.ch5
Adaptive Control with Heuristic Disturbance Rejection in T1DM: A Performance Assessment
Rebro, M., Tárník, M., & Murgaš, J. (2017) · IFAC-PapersOnLine · doi:10.1016/j.ifacol.2017.08.604 · Cited by 1
Physiological Models and Exogenous Input Modeling
Georga, E. I., Fotiadis, D. I., & Tigas, S. K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804831-3.00004-2 · Cited by 1
Control of MIMO nonlinear systems via approximate model inversion
Calafiore, G. C., & Novara, C. (2017) · IEEE Conference on Decision and Control (CDC) · doi:10.1109/cdc.2017.8264673
Reachability Analysis of Cyber-Physical Systems Using Symbolic-Numeric Techniques
Zutshi, A. (2016) · CU Scholar (University of Colorado Boulder)
Sathe, A. M. (2018) · Journal of Bioengineering and Biomedical Sciences · doi:10.4172/2155-9538.1000256
Quantitative Approaches in Translational Cardiometabolic Research: An Overview
Maleki, F., Gaitonde, P., Miller, S. A., Trame, M. N., Coen, P. M., Garhyan, P., & Schmidt, S. (2019) · Springer eBooks · doi:10.1007/978-3-030-11748-1_17
T-S Fuzzy Control for Blood Glucose Regulation in Type-1 Diabetes
Pan, J., Kang, Z., Zhang, W., et al. (2019) · Chinese Control and Decision Conference (CCDC) · doi:10.1109/ccdc.2019.8833111
Model Based Control of Blood Glucose for Type 1 Diabetic Patients Using Artificial Pancreas
Bhonsle, S., & Saxena, S. (2019)
A Study on Modeling Glucose–Insulin Dynamics
조용진 (2013) · Seoul National University Open Repository (Seoul National University)
The Computational Patient has Diabetes and a COVIDPreprint
Barbiero, P., & Lió, P. (2020) · arXiv (Cornell University) · doi:10.48550/arxiv.2006.06435
D'Souza, C. (2016) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2016-11379
MAH, U. E., & Woafo, P. (2020) · Journal of Mechanics in Medicine and Biology · doi:10.1142/s0219519420500554
Chase, J. G., & Knopp, J. L. (2020) · Research Square · doi:10.21203/rs.3.rs-75542/v1
Mathematical modelling of blood glucose regulation
Fitches, M. J. (2016) · Radar (Oxford Brookes University) · doi:10.24384/8w30-me73
Praveen, E. P., Chouhan, S., Sahoo, J., Khadgawat, R., Khurana, M. L., Gupta, N., Dwivedi, S. N., & Kulshreshtha, B. (2021) · Cureus · doi:10.7759/cureus.15056 · Cited by 1
A Century of Insulin: Outstanding Physiological Breakthroughs
Matveyenko, A. V., Sieck, G. C., & Klip, A. (2021) · Physiology · doi:10.1152/physiol.00016.2021
Adapting Protocols or Models for Use in Insulin-Requiring Diabetes and Islet Transplant Recipients
Ward, G. M., Walters, J. M., Gooley, J. L., & Boston, R. C. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.611512
Cobelli, C., & Thomaseth, K. (1985) · Lecture notes in biomathematics · doi:10.1007/978-3-642-93287-8_29
Self-citation“Is Prediabetes a Risk Factor or Is It a Disease?”
Kohlenberg, J. D., & Vella, A. V. (2021) · Wiley eBooks · doi:10.1002/9781119603207.ch1
Insulin Resistance and the Metabolic Syndrome
Banerji, M. A., Lam, M. L., & Chaiken, R. L. (2017) · Springer eBooks · doi:10.1007/978-3-319-18741-9_34
Measuring insulin action in vivo
Bergman, R. N., & Ader, M. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch15
Self-citationInsulin Resistance and the Metabolic Syndrome
Banerji, M. A., & Lam, M. L. (2016) · Springer eBooks · doi:10.1007/978-3-319-20797-1_34-1
Hypertensive disorders and diabetic pregnancy
Bar, J., & Hod, M. (2008) · Series in maternal-fetal medicine · doi:10.3109/9781439802007.041 · Cited by 1
Estrategias de control avanzadas para páncreas artificial
Fushimi, E. (2021) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/133534
Rathee, N. S. (2015) · Journal of Mathematics and System Science · doi:10.17265/2159-5291/2015.06.004
Galvanin, F., Barolo, M., Macchietto, S., & Bezzo, F. (2010) · Wiley eBooks · doi:10.1002/9783527631339.ch16
Ho, Y. (2018) · Springer theses · doi:10.1007/978-981-13-2402-4_3
Model‐Based Control of Blood Glucose for Type 1 Diabetes
Dua, P., & Pistikopoulos, E. N. (2010) · Process systems engineering · doi:10.1002/9783527631209.ch17
Parker, R. S. (2008) · CRC Press eBooks · doi:10.1201/b18990-146
Detection and Diagnosis of Syndromes of Insulin Resistance and of Diabetes Mellitus
Horton, E. S. (2002) · CRC Press eBooks · doi:10.1201/9780203910382.ch8
A. Optimization of Insulin Action
PhD, G. W. (2013) · CRC Press eBooks · doi:10.1201/b16259-23
Naftalin, R. J. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733847489.793555123
Watanabe, R. M., & Hansen, T. F. (2016) · Springer eBooks · doi:10.1007/978-3-319-01574-3_9
刘, 赛. (2022) · Software Engineering and Applications · doi:10.12677/sea.2022.114075
A Web-user interface design for mathematical model ofglucose-insulin systemPreprint
Minani, F., Harelimana, D., Bizimungu, T., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1953092/v1
A review on the existing artificial pancreas models
Nath, A., Dey, R., & Bălaş, V. E. (2022) · Elsevier eBooks · doi:10.1016/b978-0-32-390776-7.00009-6
Tiwari, P., Phatak, S. B., Bandopadhyay, S., Sethi, T., Fall, C. H. D., & Yajnik, C. S. (2022) · medRxiv · doi:10.1101/2022.10.15.22281121
Automated Insulin Infusion Regulatory System
Loh, K. M., Ghista, D. N., & Su, B. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95884-4.00011-1
IV Jornadas de Investigación de la Facultad de Ingeniería del año 2022
Arrieta, O., Díaz, V. S., & Castro-Arce, K. (2023) · Ingeniería · doi:10.15517/ri.v33ine3.53667 · Cited by 1
Central Control of Glucose Homeostasis
Alonge, K. M., Francis, K. L., Richardson, N. E., & Schwartz, M. W. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch10
İnsülin 100 Yıllık Mucize Hormon
Cerit, E. T., Barlas, T., Atalar, K., Bahçelioğlu, M., Kaplanoğlu, G. T., Seymen, C. M., Erdem, H. B., Ergün, M. A., Demir, Ö., Gülbahar, Ö., et al. (2022) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.871
Furió-Novejarque, C. (2024) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/202872
Model predictive control of blood glucose in critically ill patients using Gaussian processes
Benner, C.-F., Weber, N., Leonhardt, S. K., & Walter, M. (2024) · at - Automatisierungstechnik · doi:10.1515/auto-2024-0211
Fujita, S., Hironaka, K., Karasawa, Y., & Kuroda, S. (2024) · iScience · doi:10.1016/j.isci.2024.109833
Dalton, M., Asante-Asamani, E. O., & Greene, J. M. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.31.606029
Robust Optimal Control of Nonlinear Systems via Homotopy Shooting Method
Stein, A., & Singh, T. (2024) · Proceedings of the ... American Control Conference/Proceedings of the American Control Conference · doi:10.23919/acc60939.2024.10644235
Adaptive Control Design with Saturation Constraints for Different Experimental Glucose Models
Karima, M., & Abdelaziz, M. (2024) · Lecture notes in electrical engineering · doi:10.1007/978-981-97-0045-5_17
Control of the Glucose Insulin Glucagon System in Type 1 Diabetes
Saoussane, M., Mohamed, T., & Mesaoud, C. (2024) · Lecture notes in electrical engineering · doi:10.1007/978-981-97-0045-5_3
Metadata
- Authors
- Bergman, R. N., Phillips, L. S., & Cobelli, C.
- Affiliations
- Northwestern University (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1981-12-01
- Volume
- 68
- Issue
- 6
- Pages
- 1456-1467
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC370948
- OpenAlex
- W2156353972
- Cited by
- 1,640
- References
- 30
- Citations by year
- 2026: 32 · 2025: 38 · 2024: 44 · 2023: 31 · 2022: 45 · 2021: 59 · 2020: 50 · 2019: 55 · 2018: 66 · 2017: 66 · 2016: 59 · 2015: 63 · 2014: 60 · 2013: 59 · 2012: 73
- FWCI
- 3.42
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Funders
- Northwestern University
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK029867)
- NIH Clinical Center
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- glucose tolerance, insulin sensitivity, beta-cell glucose sensitivity, insulin resistance, pancreatic insufficiency, intravenous glucose tolerance test, first-phase insulin response, second-phase insulin response, obesity, impaired glucose tolerance, insulin kinetics, glucose kinetics
- MeSH terms
- Body Weight, Female, Glucose, Glucose Tolerance Test, Humans, Infusions, Parenteral, Insulin, Kinetics, Male, Models, Biological, Obesity, Pancreas
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.